NCT07215507 Timing of Physician Rounds for Antepartum Patients
| NCT ID | NCT07215507 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Physician Rounds |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-11-04 |
| Primary Completion | 2027-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-11-04 with a primary completion date of 2027-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will include patients admitted to the Antepartum service at Duke University Hospital, many of whom are managing high-risk pregnancies that require extended hospital stays and frequent physician interactions. Currently, two rounding methods are used interchangeably for patients who do not have pregnancy or delivery complications that would preclude participation in delayed daytime rounding. This randomized controlled trial will compare two rounding models: the standard model, in which patients receive two rounds (an early morning bedside encounter and a later team discussion), and the intervention model, which consolidates both rounds into a single, later-morning bedside encounter following the team's review of clinical data. The primary objective is to assess whether consolidating physician rounds into a single, later-morning encounter-referred to as discovery rounding-improves patient satisfaction with communication.
Eligibility Criteria
Inclusion Criteria: * Pregnant women greater than 20 weeks gestation admitted to the antepartum list at Duke University Hospital Exclusion Criteria: * Stillbirth * ICU admission * Admission to off-service unit * Active magnesium sulfate administration * Active severe hypertension or initiation of anti-hypertensive pathway within past 8 hours * Category II fetal heart rate tracing * Other pregnancy/delivery complication precluding delayed rounding * Unstable/unsuitable condition per overnight team or attending physician * Previously enrolled/on active board \>1 day at morning rounds * Postpartum readmission * Antepartum admission within the last 4 weeks
Contact & Investigator
Hannah Kelly, MD
STUDY DIRECTOR
Duke University Hospital
Frequently Asked Questions
Who can join the NCT07215507 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Physician Rounds. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07215507 currently recruiting?
Yes, NCT07215507 is actively recruiting participants. Contact the research team at hannah.kelly@duke.edu for enrollment information.
Where is the NCT07215507 trial being conducted?
This trial is being conducted at Durham, United States, Durham, United States.
Who is sponsoring the NCT07215507 clinical trial?
NCT07215507 is sponsored by Duke University. The principal investigator is Hannah Kelly, MD at Duke University Hospital. The trial plans to enroll 200 participants.